Open access · CC-BY
via OpenAlex
Oral nicotinamide mononucleotide (NMN) increases tissue NAD+ content in mice but neither NMN nor Polypodium leucotomos protect against UVR-induced skin cancer
Celina Pihl, Ravin Kara, Jonatan Riber Granborg, Uffe H. Olesen, Peter Bjerring, Merete Hædersdal, Gavrielle Rebecca Untracht, Catharina Margrethe Lerche
Photochemical & Photobiological Sciences · 2025 · ▲ 6 citations
Abstract
Abstract Keratinocyte carcinoma is the most common cancer. Oral photoprotection offers an attractive addition to classical prevention measures. Popular candidates include nicotinamide and nicotinamide mononucleotide (NMN), which are NAD+ precursors thought to facilitate DNA repair. Extracts from the Polypodium leucotomos plant (PL) are also reported to convey broad protection against ultraviolet radiation (UVR) in both human and animal models. In this study, we evaluated the efficacy of NMN and PL treatment to prevent UVR-induced tumor development in hairless mice. Oral treatment with NMN or PL did not affect tumor development evaluated by tumor onset, number, size, or growth. Oral NMN increased NAD+ content in skin compared to the UVR control (p ≤ 0.00039) and liver tissue compared to the UVR control and non-exposed mice (p ≤ 0.0466) with no effect on tumor growth. We also demonstrated that UVR exposure induced urinary excretion of thymidine dimers in mice as measured by liquid chromatography–mass spectrometry, indicating that the induction of photodamage can be monitored non-invasively throughout the study period.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1007/s43630-025-00736-5
- Canonical
- link ↗
- Fetched
- 2026-10-31 MST
Cite this
APA
Pihl, C., Kara, R., Granborg, J.R., Olesen, U.H., Bjerring, P., Hædersdal, M., Untracht, G.R., & Lerche, C.M. (2025). Oral nicotinamide mononucleotide (NMN) increases tissue NAD+ content in mice but neither NMN nor Polypodium leucotomos protect against UVR-induced skin cancer. <em>Photochemical & Photobiological Sciences</em>. https://doi.org/10.1007/s43630-025-00736-5
Vancouver
Pihl C, Kara R, Granborg JR, Olesen UH, Bjerring P, Hædersdal M, et al. Oral nicotinamide mononucleotide (NMN) increases tissue NAD+ content in mice but neither NMN nor Polypodium leucotomos protect against UVR-induced skin cancer. Photochemical & Photobiological Sciences. 2025. doi:10.1007/s43630-025-00736-5.
BibTeX
@article{celina2025Oralni,
title = {Oral nicotinamide mononucleotide (NMN) increases tissue NAD+ content in mice but neither NMN nor Polypodium leucotomos protect against UVR-induced skin cancer},
author = {Celina Pihl and Ravin Kara and Jonatan Riber Granborg and Uffe H. Olesen and Peter Bjerring and Merete Hædersdal and Gavrielle Rebecca Untracht and Catharina Margrethe Lerche},
journal = {Photochemical & Photobiological Sciences},
year = {2025},
doi = {10.1007/s43630-025-00736-5},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
IUBMB Life 2023
Open access · OA
Nicotinamide mononucleotide alters body composition and ameliorates metabolic disorders induced by a high‐fat diet
Scientific Reports 2017
Open access · CC-BY
Nicotinamide mononucleotide (NMN) supplementation ameliorates the impact of maternal obesity in mice: comparison with exercise
Research Square 2026
Preprint · CC-BY
Long-term NMN treatment increases lifespan and healthspan in mice in a sex dependent manner
Journal of Neurochemistry 2021
Open access · CC-BY
Sex‐specific alterations in NAD+ metabolism in 3xTg Alzheimer’s disease mouse brain assessed by quantitative targeted LC‐MS
Aging Cell 2016
Open access · CC-BY
Nicotinamide mononucleotide supplementation reverses vascular dysfunction and oxidative stress with aging in mice
Journal of Drugs in Dermatology 2022
Open access · OA